Summary

Market Size & Trends

The U.S. longevity and general wellness supplements market size was estimated at USD 6.01 billion in 2024 and is projected to grow at a CAGR of 6.02% from 2025 to 2033. This sustained growth is driven by rising consumer awareness around preventive health, aging populations seeking to extend health spans, and increased interest in personalized wellness solutions.

Innovations in formulation, science-backed ingredients, and the expanding availability of supplements through e-commerce and retail channels are expected to fuel market expansion over the forecast period.

Evolving Consumer Demographics

The evolving demographic landscape in the U.S. is a major catalyst for the growing demand for longevity and general wellness supplements. According to U.S. Census data, as the Baby Boomer generation ages, the population of individuals 65 and older is projected to nearly double by 2060. This shift creates sustained demand for products supporting healthy aging, mobility, cognitive function, and chronic disease prevention

Moreover, younger generations, Millennials and Gen Z, focus on preventive health and wellness optimization. These groups are more proactive about their health, often adopting supplements as part of daily routines to boost immunity, manage stress, improve skin health, and enhance longevity from an earlier age. This intergenerational interest is expanding the market's consumer base, driving innovation in formulation, personalization, and delivery formats. The combined effect of an aging population and health-conscious younger consumers is reshaping market dynamics, fostering long-term growth opportunities for brands that cater to diverse age groups with targeted, science-backed wellness solutions.

U.S. Longevity & General Wellness Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. longevity & general wellness supplements market report based on application:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Longevity Supplements
o Type
o NMN
o NR
o NAD+
o NADH
o Resveratrol
o Fisetin
o Quercetin
o Cucurmin
o Collagen
o Pterostilbene
o Others
o Sales Channel
o Online
o Direct to consumer
o Other e-commerce channels
o Offline
o Hypermarkets/Supermarkets
o Pharmacies & Drug Stores
o Others
• General Wellness Supplements
o Type
o Vitamins
o Multivitamins
o Individual vitamins
o Minerals
o Amino acids
o Probiotics
o Collagen
o Fish oils
o Coenzyme Q10
o Herbal extracts
o Others
o Sales Channel
o Online
o Direct to consumer
o Other e-commerce channels
o Offline
o Hypermarkets/Supermarkets
o Pharmacies & Drug Stores
o Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Application Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Longevity & General Wellness Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Longevity & General Wellness Supplements Market: Application Business Analysis
4.1. Application Segment Dashboard
4.2. U.S. Longevity & General Wellness Supplements Market Application Movement Analysis
4.3. U.S. Longevity & General Wellness Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.4. Longevity Supplements
4.4.1. U.S. Longevity Supplements based Market, 2021 - 2033 (USD Million)
4.4.1.1. Longevity Supplements Type
4.4.1.1.1. Longevity Supplements Type based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.1. NMN
4.4.1.1.1.1.1. NMN based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.2. NR
4.4.1.1.1.2.1. NR based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.3. NAD+
4.4.1.1.1.3.1. NAD+ based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.4. NADH
4.4.1.1.1.4.1. NADH based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.4.2. Resveratrol
4.4.1.1.1.4.3. Resveratrol based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.5. Fisetin
4.4.1.1.1.5.1. Fisetin based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.6. Quercetin
4.4.1.1.1.6.1. Quercetin based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.7. Cucurmin
4.4.1.1.1.7.1. Cucurmin based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.8. Collagen
4.4.1.1.1.8.1. Collagen based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.9. Pterostilbene
4.4.1.1.1.9.1. Pterostilbene based Market, 2021 - 2033 (USD Million)
4.4.1.1.1.10. Others
4.4.1.1.1.10.1. Others based Market, 2021 - 2033 (USD Million)
4.4.1.2. Longevity Supplements Sales Channel
4.4.1.2.1. Longevity Supplements Sales Channel based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.1. Online
4.4.1.2.1.1.1. Online Sales Channel based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.1.2. Direct to consumer
4.4.1.2.1.1.2.1. Direct to consumer-based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.1.3. Other e-commerce channels
4.4.1.2.1.1.3.1. Other e-commerce channels-based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.2. Offline
4.4.1.2.1.2.1. Offline Sales Channel based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.2.2. Hypermarkets/Supermarkets
4.4.1.2.1.2.2.1. Hypermarkets/Supermarkets-based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.2.3. Pharmacies & Drug Stores
4.4.1.2.1.2.3.1. Pharmacies & Drug Stores-based Market, 2021 - 2033 (USD Million)
4.4.1.2.1.2.4. Others
4.4.1.2.1.2.4.1. Others based Market, 2021 - 2033 (USD Million)
4.5. General Wellness Supplements
4.5.1. U.S. General Wellness Supplements Market, 2021 - 2033 (USD Million)
4.5.1.1. General Wellness Supplements Type
4.5.1.1.1. General Wellness Supplements Type based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.1. Vitamins
4.5.1.1.1.1.1. Vitamins based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.1.2. Multivitamins
4.5.1.1.1.1.2.1. Multivitamins based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.1.3. Individual vitamins
4.5.1.1.1.1.3.1. Individual vitamins-based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.2. Minerals
4.5.1.1.1.2.1. Minerals based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.3. Amino acids
4.5.1.1.1.3.1. Amino acids-based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.4. Probiotics
4.5.1.1.1.4.1. Probiotics based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.5. Collagen
4.5.1.1.1.5.1. Collagen based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.6. Fish oils
4.5.1.1.1.6.1. Fish oils based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.7. Coenzyme Q10
4.5.1.1.1.7.1. Coenzyme Q10 based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.8. Herbal extracts
4.5.1.1.1.8.1. Herbal extracts based Market, 2021 - 2033 (USD Million)
4.5.1.1.1.9. Others
4.5.1.1.1.9.1. Others based Market, 2021 - 2033 (USD Million)
4.5.1.2. General Wellness Supplements Sales Channel
4.5.1.2.1. General Wellness Supplements Sales Channel based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.1. Online
4.5.1.2.1.1.1. Online Sales Channel based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.1.2. Direct to consumer
4.5.1.2.1.1.2.1. Direct to consumer-based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.1.3. Other e-commerce channels
4.5.1.2.1.1.3.1. Other e-commerce channels-based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.2. Offline
4.5.1.2.1.2.1. Offline Sales Channel based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.2.2. Hypermarkets/Supermarkets
4.5.1.2.1.2.2.1. Hypermarkets/Supermarkets-based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.2.3. Pharmacies & Drug Stores
4.5.1.2.1.2.3.1. Pharmacies & Drug Stores-based Market, 2021 - 2033 (USD Million)
4.5.1.2.1.2.4. Others
4.5.1.2.1.2.4.1. Others based Market, 2021 - 2033 (USD Million)
Chapter 5. Competitive Landscape
5.1. Company Categorization
5.2. Strategy Mapping
5.3. Company Market Position Analysis, 2024
5.4. Company Profiles/Listing
5.4.1. NOW Foods
5.4.1.1. Overview
5.4.1.2. Financial Performance
5.4.1.3. Product Benchmarking
5.4.1.4. Strategic Initiatives
5.4.2. Life Extension
5.4.2.1. Overview
5.4.2.2. Financial Performance
5.4.2.3. Product Benchmarking
5.4.2.4. Strategic Initiatives
5.4.3. Nature’s Bounty
5.4.3.1. Overview
5.4.3.2. Financial Performance
5.4.3.3. Product Benchmarking
5.4.3.4. Strategic Initiatives
5.4.4. Jarrow Formulas
5.4.4.1. Overview
5.4.4.2. Financial Performance
5.4.4.3. Product Benchmarking
5.4.4.4. Strategic Initiatives
5.4.5. Nature’s Way
5.4.5.1. Overview
5.4.5.2. Financial Performance
5.4.5.3. Product Benchmarking
5.4.5.4. Strategic Initiatives
5.4.6. Thorne
5.4.6.1. Overview
5.4.6.2. Financial Performance
5.4.6.3. Product Benchmarking
5.4.6.4. Strategic Initiatives
5.4.7. Himalaya Wellness (US)
5.4.7.1. Overview
5.4.7.2. Financial Performance
5.4.7.3. Product Benchmarking
5.4.7.4. Strategic Initiatives
5.4.8. Pure Encapsulations
5.4.8.1. Overview
5.4.8.2. Financial Performance
5.4.8.3. Product Benchmarking
5.4.8.4. Strategic Initiatives
5.4.9. Hims & Hers Health, Inc.
5.4.9.1. Overview
5.4.9.2. Financial Performance
5.4.9.3. Product Benchmarking
5.4.9.4. Strategic Initiatives
5.4.10. Ro
5.4.10.1. Overview
5.4.10.2. Financial Performance
5.4.10.3. Product Benchmarking
5.4.10.4. Strategic Initiatives
5.4.11. Elysium Health
5.4.11.1. Overview
5.4.11.2. Financial Performance
5.4.11.3. Product Benchmarking
5.4.11.4. Strategic Initiatives
5.4.12. Niagen Bioscience
5.4.12.1. Overview
5.4.12.2. Financial Performance
5.4.12.3. Product Benchmarking
5.4.12.4. Strategic Initiatives
5.4.13. ProHealth
5.4.13.1. Overview
5.4.13.2. Financial Performance
5.4.13.3. Product Benchmarking
5.4.13.4. Strategic Initiatives
5.4.14. RevGenetics
5.4.14.1. Overview
5.4.14.2. Financial Performance
5.4.14.3. Product Benchmarking
5.4.14.4. Strategic Initiatives
5.4.15. Codeage LLC
5.4.15.1. Overview
5.4.15.2. Financial Performance
5.4.15.3. Product Benchmarking
5.4.15.4. Strategic Initiatives